SCHEMBL6775522

SCHEMBL6775522

CC(=O)NC(Cc1ccccc1N)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNPAT O15228 1/20 0.47
TNF P01375 1/20 0.44
ALOX15 P16050 2/20 0.44
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44
LMNA P02545 1/20 0.44
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
PAM P19021 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
NFKB1 P19838 1/20 0.43
PTGS2 P35354 1/20 0.43
THPO P40225 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MME P08473 3/20 0.43
ACE P12821 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27744244 0.84 KMT2A (0.41) ALOX15KDM4EMAPTSMN1; SMN2MME
SCHEMBL27744242 0.84 KMT2A (0.41) ALOX15KDM4EMAPTSMN1; SMN2MME
SCHEMBL7059635 0.84 ERAP2 (0.48) GNPATTNFALOX15ITGB3ITGA2B
SCHEMBL8815317 0.83 L3MBTL1 (0.52) GNPATTNFALOX15LMNACTSS
SCHEMBL503585 0.81 TNF (0.53) GNPATTNFALOX15ITGB3ITGA2B
SCHEMBL29398464 0.81 CTSS (0.48) GNPATTNFALOX15LMNACTSS
SCHEMBL2152925 0.81 TNF (0.50) GNPATTNFALOX15LMNACTSS
SCHEMBL2153481 0.81 CTSS (0.48) GNPATTNFALOX15LMNACTSS
SCHEMBL6377776 0.81 TNF (0.50) GNPATTNFALOX15LMNACTSS
SCHEMBL503584 0.81 TNF (0.53) GNPATTNFALOX15ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6833382-B2 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92 AVENTIS PHARMA S.A. (FR) 2004-12-21 US disclosed